B12 – Conducting Medical Device Trials in Australia: Insights into how to succeed

Recent TGA data shows that over 50% of all clinical trials involve devices either alone (14%) or in combination with medicines (38%) and this number is increasing. Hence there are increasing opportunities for people wanting to work in this field of research. This session will cover:

  • How medical device trials differ to pharma trials
  • Australian case studies
  • How to take a product from the benchtop to first in man studies
  • Insights from the sites perspective about conducting device vs pharma trials

Chairperson: Catherine Bourgeois, Vice President, Field Clinical Affairs, Emerging Markets & ANZ, Abbott